Agendia provides molecular diagnostics and personalized treatment plans for cancer patients.
Industries BiotechnologyGeneticsHealth CareHealth DiagnosticsLife ScienceMedicalHeadquarters Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Founded Date 2003 Founders Bernhard Sixt, Rene Bernards Operating Status Active Last Funding Type Private Equity Legal Name Agendia, Inc.
Company Type For Profit
Contact Email customercare@agendia.com Phone Number (204) 621-500_
Agendia's molecular diagnostic technology provides cancer patients and their physicians with a glimpse into their genome, answers to the most pressing questions and enables personalized treatment plans. Agendia’s breast cancer tests were developed using an unbiased gene selection by analyzing the complete human genome. Agendia’s tests can
help physicians assess a patient’s individual risk for metastasis, which patients may benefit from chemo, hormonal or combination therapy, and which patients may not require these treatments and can instead be treated with other, less arduous and less costly methods.
Product Name | Product Description |
---|---|